Moberg Pharma AB (publ) (STO:MOB)

Sweden · Delayed Price · Currency is SEK

10.78

-0.12 (-1.10%)

May 6, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Commercialization and Development of Medical Products				207.00K		33.66M	50.49M	31.11M	4.55M
Commercialization and Development of Medical Products Growth				-		-33.33%	62.30%	583.24%	-98.96%
Total				207.00K		33.66M	50.49M	31.11M	4.55M
Total Growth				-		-33.33%	62.30%	583.24%	-98.96%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Europe				-		-	-	31.11M	-
Rest of The World				207.00K		33.66M	-	-	-
America				-		-	-	-	4.55M
America Growth				-		-	-	-	-98.85%
Total				207.00K		33.66M	-	31.11M	4.55M
Total Growth				-		-	-	583.24%	-98.96%

Source: S&P Global Market Intelligence.